Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04616196
Title A Phase 1b/2 Study of NKTR 255 in Combination With Cetuximab in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nektar Therapeutics
Indications

colorectal cancer

head and neck squamous cell carcinoma

Therapies

Cetuximab + NKTR-255

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.